Incisive Genetics Inc.

10 enregistrements totalisant 1,576,018.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.

Intégrer ce graphique

Par ministère

Conseil national de recherches Canada $1,576,018 10 enregistrements

Enregistrements

Incisive Genetics Inc. $545,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2023-2024
Canada

This project will expand the chemistry, manufacturing and controls (CMC) workup of lead formulation materials. This will involve the development of additional quality control measures as well as the...

Incisive Genetics Inc. $375,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2022-2023
Canada

The project will involve the development of expanded Huntington's Disease gene therapy strategies, addition of retinal and bone marrow targeting capabilities, and demonstration of the delivery of alte...

Incisive Genetics Inc. $252,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2021-2022
Canada

The proposed project will involve repeat dose testing in a Huntington's Disease model to demonstrate the ability to perform titratable genome editing. Additionally the project will involve proof of co...

Incisive Genetics Inc. $132,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2020-2021
Canada

This project will involve determining optimal route of administration of Transfection Competent Vesicle (TCV) delivery of gene editing machinery in vivo efficacy studies to generate critical proof of...

Incisive Genetics Inc. $100,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program
EF 2026-2027
Canada

The project will to develop and optimize a process to synthesize and purify the key lipid components for technology transfer of the process to an accredited Good Manufacturing Practice (GMP) facility.

Incisive Genetics Inc. $56,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2019-2020
Canada

This project aims to evaluate and determine the effectiveness of a proprietary formulation in the delivery of nucleic acids and gene editing cargo into suspension cell types.

Incisive Genetics Inc. $56,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2019-2020
Canada

This project will involve the delivery of mRNA and selected guiding gene materials (RNAs) to cells in vitro using Transfection competent vesicle (TCV) to evaluate and determine the suitability of TCVs...

Incisive Genetics Inc. $28,852.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
EF 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

Incisive Genetics Inc. $20,328.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
EF 2020-2021
Canada

The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.

Incisive Genetics Inc. $10,838.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
EF 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.